zuma-12: axicabtagene ciloleucel for high-risk large b cell lymphoma
Published 3 years ago • 42 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
3:16
zuma-12: a phase 2 study of axi-cel as first-line therapy in patients with high-risk large b-cel...
-
2:06
zuma-12: axi-cel as first-line therapy in high-risk large b-cell lymphoma
-
2:17
zuma-12: axicabtagene ciloleucel as a first-line therapy in patients with high-risk lbcl
-
7:12
zuma-12 study assesses car t-cell therapy as frontline treatment for large b-cell lymphoma
-
4:11
interim results of the zuma-12 trial: car t-cell therapy for large b-cell lymphoma
-
3:10
axicabtagene ciloleucel in patients with refractory large b cell lymphoma
-
4:26
axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large b-cell lymphoma
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
5:54
zuma-5 update: axicabtagene ciloleucel continues to show strong effect in r/r inhl
-
5:50
large b-cell lymphoma: zuma-1 trial
-
6:51
axicabtagene ciloleucel for patients with non-hodgkin lymphoma
-
3:15
zuma-12: is car t-cell therapy effective in high-risk dlbcl as first-line therapy?
-
2:21
refractory large b cell lymphoma treated with axicabtagene ciloleucel
-
4:00
retreatment of patients with refractory large b-cell lymphoma with axicabtagene ciloleucel in zuma-1
-
2:48
zuma-1: safety and efficacy of axicabtagene in refractory non-hodgkin lymphoma patients
-
4:52
long term follow up on the zuma-1 trial for nhl
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
3:10
zuma-9: expanded access protocol and oos axicabtagene ciloleucel in r/r dlbcl
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma